Skip to content

Original Research

Frontiers in Virology ·

Volume 6 - 2026 | https://doi.org/10.3389/fviro.2026.1907549

Immuno-pathological studies of lumpy skin disease outbreaks in cattle

  • Gunasekaran Vigneshwar1,2
  • Lakkawar Warundeo Avinash2
  • Ansar Aaqib Javed2
  • Tadakod Sunil1
  • Mathiazhagan Abhinaya2
  • Hirak Kumar Mukhopadhyay2
  • Kaliaperumal Rajalakshmi2
  • Subbarayan Poobitha2
  • Sambath Uma2
  • Raja Kumar2
  • Nair Madhavan Gopalakrishnan2
  • Bijalwan Sharddha1
  • Uma Ramesh Chandana1
  • Gundallahalli Bayyappa Manjunatha Reddy1*corresponding author
  1. 1Indian Council of Agriclutural Research (ICAR)-National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI), Bengaluru, India
  2. 2Rajiv Gandhi Institute of Veterinary Education and Research, Puducherry, India
Article metrics0 viewsView details

Abstract

Lumpy skin disease (LSD) is a transboundary viral disease of cattle caused by the lumpy skin disease virus (LSDV), leading to significant economic losses in livestock. The present study investigated the clinical, hematological, and pathological alterations and expression of cytokine genes in cattle naturally affected by LSD. A total of 21 clinically affected individuals were examined and classified into early, mid, and late stages. The study focused on key diagnosis of LSD by clinical findings, hematology, indirect ELISA, histopathology, immunohistochemistry, PCR, and the relative expression of cytokine genes associated with both proinflammatory (IL-2, IFN-g, and GM-CSF) and anti-inflammatory (IL-4, and IL-10) responses using real-time PCR. Affected animals exhibited stage-dependent clinical signs. Hematological analysis revealed a significant increase in total leukocyte count (TLC) and absolute lymphocyte count (ALC) in late-stage LSD cases, reflecting an active inflammatory response. PCR detected LSDV DNA in 52.4% of nasal swabs and 57.1% of skin biopsy samples. The cytokine gene expression analysis showed a downregulation of IL-2, IL-4, IL-10, IFN-g, and GM-CSF in both peripheral blood mononuclear cells (PBMCs) and skin tissue samples from LSD-affected cattle, suggesting an impaired immune response. This reduced expression likely contributes to the persistence of LSDV in affected cattle, leading to prolonged inflammation and increased susceptibility to secondary infections. In contrast, healthy cattle exhibited a stronger Th1 cell response, indicating better immune regulation and disease resilience. The findings highlight the role of immune dysregulation in the progression of LSD and suggest that cytokine modulation by LSDV is a key mechanism for immune evasion.

Keywords

1 Introduction

Lumpy skin disease is a highly contagious viral disease caused by lumpy skin disease virus, a member of the Capripoxvirus genus within the Poxviridae family (1). Although historically confined to Africa, the disease has rapidly expanded into the Middle East and Asia and has emerged as one of the most significant transboundary animal diseases affecting cattle (2), mithun (3), and yak (4). The disease, which affects cattle, buffalo, and wild ruminants, is characterized by the development of cutaneous skin nodules that progress to necrotic lesions, predisposing affected animals to secondary bacterial infections such as myiasis (5). The disease results in substantial economic losses through reduced milk yield, weight loss, infertility, abortion, hide damage, treatment costs, restrictions on animal movement and trade, and, in severe cases, death (6). The LSD outbreak in India resulted in over 155,000 cattle deaths and caused an estimated economic loss of 2217.26 million USD, highlighting the significant threat posed by the disease to the livestock sector (7).

Transmission of LSDV occurs through both direct and indirect routes. Direct transmission occurs through contact with infected body fluids, while indirect transmission is via biting vectors like flies and ticks (2). Following infection, the virus replicates in susceptible host cells, leading to the development of clinical signs including fever, nasal discharge, enlargement of lymph nodes, characteristic skin nodules, pneumonia, and mastitis. Infected animals shed the virus through various body fluids such as blood, serum, milk, semen, and oral, nasal, and lacrimal discharges, contributing to disease transmission (8).

The disease severity varies considerably among affected animals and is influenced by factors such as age, breed, immune status, and environmental conditions (9). Based on the clinical signs, LSD infection is categorized into early, mid, and late stages (6, 10). Diagnosis of LSD is based on characteristic clinical signs, pathological lesions, and various laboratory techniques such as PCR (11), ELISA (12), and virus isolation (13). Although clinical diagnosis is often straightforward in advanced cases, laboratory confirmation remains essential because several dermatological and poxviral infections can produce similar lesions. Among the available diagnostic techniques, PCR provides rapid and specific detection, whereas histopathology and immunohistochemistry facilitate understanding of tissue alterations and viral localization.

The genetic makeup of individual animals plays a crucial role in determining their immune response to the same strain of the LSD virus, as well as the distribution of disease transmitting vectors within the environment influence the epidemiology and severity of the disease (14, 15). Understanding the genetic factors underlying host responses to LSDV is essential to uncover the mechanisms behind the immune response to LSD (16). In particular, Investigating the regulation of cytokines involved in inflammation can provide valuable biomarkers. These biomarkers could help distinguish between animals that are susceptible to infection and those that are more tolerant or resilient to the disease. Although recovered animals develop immunity, factors such as virus strain, host immunity, and vector prevalence influence disease severity (6, 17). Despite the growing impact of LSD worldwide, there is a paucity of information on the understanding of the genetic and immune responses to LSD in Cattle, including cytokine involvement, to improve diagnostic and treatment strategies.

Despite the increasing prevalence of LSD in India, information integrating clinical observations, pathological lesions, molecular diagnosis, immunohistochemical localization and cytokine responses under natural field conditions remains limited. Therefore, the present study was designed and undertaken to diagnose LSD by various techniques and also to study the hematological alterations and the expression of pro-inflammatory and anti-inflammatory cytokine genes in LSD-affected cattle in Pondicherry and adjacent areas of Tamil Nadu, India.

2 Methodology

2.1 Study design and sample collection

The study population is confined to Puducherry and contiguous areas of Tamil Nadu, India. The study was conducted on 21 cattle (adults, n = 4; calves, n = 17) clinically suspected of lumpy skin disease. The healthy cattle (n = 6) were included as controls for the study. Among the affected group, the animals were re-classified into early (0 to 7 days, n = 9), mid (7 to 14 days, n = 6), and late (14 to 21 days and more, n = 6) stages of the LSD based on the days from which the animal has been suffering from the clinically shown LSD signs after the incubation period.

During the LSD outbreak, field investigations were carried out, and clinical samples were collected aseptically from clinically affected and healthy cattle in accordance with the guidelines set by the World Organisation for Animal Health (WOAH) for laboratory investigations. Additionally, a structured questionnaire was employed to gather essential information regarding the sampled animals, including age, sex, breed, and demographic details during sample collection. All animals were subjected to detailed clinical examinations; clinical observations included fever, body temperature, respiratory signs, edema, presence and distribution of skin nodules, ulceration, lesion progression with pyrexia, and decreased production performance.

Nasal swabs were collected by carefully inserting a sterile, flexible, fine-shafted swab into the nasopharyngeal cavity and gently rotating it to absorb secretions. The swabs were subsequently placed into sterile collection tubes containing 1 mL of viral transport medium (RPMI-1940). Whole blood was drawn via jugular vein puncture and collected in ethylene diamine tetra acetic acid (K2EDTA, Labtech-coated) vacutainers. Skin nodules or scabs from the lesions were collected in RNA later using the punch biopsy needle. To ensure sample integrity, all specimens were transported in insulated shipping containers with dry-ice packs, maintaining a strict cold chain. Samples were analyzed at the BSL-2+ virology laboratory, Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics (ICAR-NIVEDI), under the approval of the Institute Animal Ethics Committee (No. NIVEDI/IAEC/2022/06), Bengaluru. All samples were subsequently stored at -20 °C except for blood samples, which were preserved at 4 °C.

2.2 Hematological analysis

Whole blood samples collected aseptically from each cattle into EDTA-coated vacutainers were transported to the laboratory for hematological evaluation. Hematological parameters including hemoglobin concentration (Hb; g/dL), packed cell volume (PCV; %), total erythrocyte count (TEC; ×106/mm3), total leukocyte count (TLC; ×103/mm3), absolute leukocyte count (all expressed as ×10³/µL), mean corpuscular volume (MCV; fL), mean corpuscular hemoglobin (MCH; pg), mean corpuscular hemoglobin concentration (MCHC; g/dL), and platelet count (×105/µL) were analyzed using an automated Veterinary Hematology Analyzers (Mindray, 5-part differential hematology analyzer, China) according to the manufacturer’s instructions.

Data were represented as mean ± standard deviation (SD). Statistical analyses were conducted using the Statistical Package for the Social Sciences (IBM® SPSS® version 27). Differences among the control, clinically affected early, mid, and late-stage LSD groups were analyzed using one-way analysis of variance (ANOVA). Following the observed significant differences, post hoc multiple comparison analysis was performed to determine differences between groups. A value of p < 0.05 was considered as statistically significant.

2.3 Molecular detection of LSDV

The collected samples were thawed to room temperature before processing. Nasal swabs were vortexed thoroughly and aliquoted for extraction. Approximately 30 mg of skin nodules or scab samples were finely chopped using a sterile Bard Parker blade, and a tissue homogenate was prepared by triturating the sample with 1 mL of chilled 1X phosphate-buffered saline (PBS, pH 7.2) using a mortar and pestle. The total genomic DNA was extracted from the processed clinical samples using the DNeasy Blood and Tissue Kit (QIAGEN, Hilden, Germany), following the manufacturer’s protocol. DNA concentration and purity were assessed using a Nanodrop spectrophotometer (NABI, Microdigital Co., Ltd., South Korea). The extracted DNA was stored at -20 °C until further use. All biological materials were disposed of in accordance with the standard operating procedures (SOPs) established by the Institute Biosafety Committee (IBSC).

Diagnostic screening for the presence of lumpy skin disease virus (LSDV) was conducted on clinical affected samples, including nasal swabs (n = 21), and skin tissue (n = 21) from the same cattle. DNA was amplified for the Capripoxvirus-specific partial P32 gene using respective forward (F: 5’-TTTCCTGATTTTTCTTACTAT-3’) and reverse (R: 5’-AAATTATATACGTAAATAAC-3’) primers. Amplification of the expected 192 bp DNA fragment was considered positive for LSDV infection (6).

Conventional polymerase chain reaction (PCR) assay was performed using a Bio-Rad thermal cycler (Hercules, CA, USA) with a total reaction volume of 25 μL. The reaction mixture comprised 12.5 μL of PCR master mix (DreamTaq Green PCR Master Mix 2X, Thermo Scientific, Waltham, MA, USA), 1 μL each of forward and reverse primers (10 pmol/μL), 8.5 μL of nuclease-free water, and 50 ng of template DNA. PCR amplification was performed with an initial denaturation step at 94 °C for 5 minutes, followed by 30 amplification cycles consisting of denaturation at 94 °C for 1 minute, annealing at 50 °C for 30 s, and extension at 72 °C for 1 minute. A final extension step was carried out at 72 °C for 5 minutes. Following amplification, PCR products were analyzed via agarose gel electrophoresis on a 1.5% agarose gel prepared in 1X Tris-acetate-EDTA (TAE) buffer, stained with ethidium bromide (10 mg/ml, HiMedia Laboratories Pvt. Ltd.), and visualized under a UV transilluminator using a Gel Documentation System (Vilber Bio-Print, Vilber Lourmat, France).

2.4 Histopathological examination

The skin tissues from suspected LSD-affected and apparently from healthy cattle specimens were fixed in 10% Neutral Buffered Formalin (NBF), stored at room temperature and processed by the routine paraffin-embedding technique. 3-5µm thick tissue sections were prepared with a rotary microtome (Leica Biosystems). After deparaffinization, tissue sections were stained with Hematoxylin and Eosin, were further examined microscopically for histopathological investigations associated with LSDV infection (18).

2.5 Immunohistochemistry

Immunohistochemistry (IHC) was performed to confirm LSDV infection to determine the LSD viral antigen distribution in the skin biopsy tissues. Tissue sections were mounted on poly-L-lysine pre-coated slides and allowed to dry overnight at room temperature. The sections were subsequently deparaffinized, rehydrated and subjected to antigen retrieval using pressure-cooking method in citrate buffer at 37 °C for 5 minutes.

Endogenous peroxidase activity was blocked by covering the whole tissue sections with 3% hydrogen peroxide (H2O2) in methanol and incubated at room temperature for 10 minutes, followed by three washes with 0.01 M PBS. Non-specific antibody was blocked using 1.5% rabbit serum for one hour at room temperature.

The primary antibody was added directly to completely cover the tissue sections and incubated at room temperature for one and a half hour. Rabbit anti-bovine IgG-horseradish peroxidase (HRP)-conjugated secondary antibody (1:1000 dilution) was added and incubated at room temperature for one hour. Immunoreactivity was visualized using 3,3’-diaminobenzidine tetrahydrochloride (DAB) as the chromogen and incubated at room temperature for 2–4 minutes, or until the desired color (light brown) was developed. Between each step, the sections were washed with 0.01 M PBS.

Nuclear staining was performed using Harris Hematoxylin for 1 minute 30 seconds, followed by washing in distilled water, dehydrated in graded alcohol, clearing in xylene, and mounted with DPX (Dystrene Polystyrene Xylene). Positive immunostaining for LSDV antigen was visualized as granular golden-brown deposits within the affected tissues. Immunohistochemically stained sections were captured using an Optika B5 microscope (Optika, Italy) and documented with an Optika digital camera.

2.6 Indirect enzyme-linked immunosorbent assay

An in-house indirect ELISA was performed to detect antibodies against lumpy skin disease virus (LSDV) in serum samples. Recombinant LSDV antigen developed by ICAR-NIVEDI was coated onto ELISA plates using carbonate-bicarbonate buffer (pH 9.6) and incubated overnight at 4 °C. The plates were subsequently washed three times with phosphate-buffered saline containing 0.05% Tween-20 (PBST) and blocked with 1% bovine gelatin prepared in PBST for 1 hour at 37 °C.

After blocking, the plates were washed three times with PBST, and serum samples along with known positive and negative control sera, diluted at 1:150 in PBST, were added and incubated for 1 hour at 37 °C. After incubation, plates were washed and rabbit anti-bovine IgG horseradish peroxidase (HRP) conjugate (Bethyl Laboratories), diluted 1:7500 in blocking buffer was added to each well and incubated for an additional 1 hour at 37 °C.

Color development was achieved using ortho-phenylenediamine dihydrochloride (OPD; Sigma-Aldrich) as the substrate, and optical density (OD) was measured at 492 nm using a Tecan Infinite F50 ELISA plate reader. The percentage positivity (PPV) was obtained for each serum sample by calculating the ratio of the difference in the OD value of the test serum and negative serum control to the difference in the OD value of the positive serum control and negative serum control. Serum samples exhibiting a PPV greater than 35% were considered positive for LSDV antibodies.

2.7 Cytokine expression analysis

Peripheral blood mononuclear cells (PBMCs) were isolated from the whole blood (4 ml) samples using Histopaque (HiSep™ LSM 1077, HiMedia, LS001) according to the manufacturer’s instructions. The isolated PBMCs were stained with Trypan Blue, and viable cells were counted using a hemocytometer.

For cytokine expression analysis, samples from cattle representing the early (n = 2), mid (n = 2), and late (n = 2) stages of LSD infection and control (n = 2) were selected. Total RNA was isolated from both the PBMCs and skin tissues samples using the Hybrid-R™ RNA Isolation Kit (HB3500, v.2.1; GeneAll Biotechnology Co., Ltd., Korea) according to the manufacturer’s protocol. The quality and integrity of the RNA was assessed prior to downstream applications. RNA was then reverse transcribed into cDNA using a commercial cDNA synthesis kit.

The relative expression of five cytokine genes representing Th1 and Th2 immune responses was evaluated by quantitative real-time PCR (qPCR). The selected Th1-associated cytokines included interleukin-2 (IL-2), interferon-gamma (IFN-γ), and granulocyte-macrophage colony-stimulating factor (GM-CSF), whereas interleukin-4 (IL-4) and interleukin-10 (IL-10) represented Th2-associated cytokines. Gene-specific primers used for amplification were adopted from 17, and their sequences, annealing temperatures, and expected amplicon sizes are presented in Table 1.

Table 1. Shows primer sequences used for quantitative real-time PCR analysis of cytokine gene expression in peripheral blood mononuclear cells (PBMCs) and skin tissues of cattle (17).

Sl No.GenePrimer sequence (5’-3’)Annealing temperature of the primerAmplicon size
1IL-2F: GCCCAAGGTTAACGCTACAG56°C104 bp
R: GGTTCAGGTTTTTGCTTGGA
2IL-4F: CCACACGTGCTTGAACAAAT58°C107 bp
R: TCAGCGTACTTGTGCTCGTC
R: TAAGTTGTGTGCCCAGTGGA
3IL-10F: TGTTGACCCAGTCTCTGCTG56°C136 bp
R: TTCACGTGCTCCTTGATGTC
4IFN-γF: GGCTTTTGGGTTTTTCTGGT56°C110 bp
R: AGGCCCACCCTTAGCTACAT
5GM-CSFF: AGAAGTGAAGCAGGCCAAAC57°C108 bp
R: TCCCTCCAGTGTGAAGATCC
6GAPDHF: TGACCCCTTCATTGACCTTC57°C143 bp
R: GATCTCGCTCCTGGAAGATG

IL-2, Interleukin-2; IL-4, Interleukin-4; IL-10, Interleukin-10; IFN-γ – Interferon-gamma; GM-CSF – Granulocyte Macrophage, Colony Stimulating Factor; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.

Real-time PCR was performed in a 20 µL reaction volume containing 2 µL of cDNA template, 10 µL of PowerUp™ SYBR™ Green Master Mix (Applied Biosystems, Thermo Fisher Scientific), 1 µL each of forward and reverse primers, and nuclease-free water to make up the final volume. Amplification was carried out using a QuantStudio™ 3 Real-Time PCR System (Applied Biosystems, Thermo Fisher Scientific), and fluorescence data were analyzed using QuantStudio™ Design and Analysis Software v1.4.3.

The housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the endogenous reference gene for normalization. Relative gene expression levels were calculated using the comparative Ct (2^−ΔΔCt) method and expressed as fold changes relative to the healthy control group (19).

3 Results

3.1 Epidemiological observations

The present study was carried out during the period October 2023 to March 2024 at Puducherry and the adjoining states. Clinically affected cattle for the study were selected from both field cases and veterinary dispensaries. From all the animals, signalment (breed, age, and sex), clinical signs, and stage of the disease were recorded in a proforma. The data are presented in Table 2. Among the 21 clinically affected cattle, crossbred Jersey constituted the majority of cases. Females accounted for 90.5% of affected animals, where males represented 9.5%. A higher proportion of cases were observed in cattle below 1 year of age compared with adults.

Table 2. Shows the demographic and epidemiological data of cattle affected with LSD.

S.NoSampleVillageStateBreedAgeSexStage of disease
1Py - E - 1MadagadipattuPuducherryCBJ*2.5 YearsFemaleEarly
2Py - E -2MadagadipattuPuducherryCBJ*3 monthsFemaleEarly
3Py - E - 3LawspetPuducherryCBJ*3 YearsFemaleEarly
4Py - E - 4ThavalakuppamPuducherryCBJ*3.5 YearsFemaleEarly
5Py - E - 5BahourPuducherryCBHF#2.5 monthsFemaleEarly
6Py - E - 6BahourPuducherryCBJ*3 monthsFemaleEarly
7Py - E - 7EmbalamPuducherryCBJ*4 monthsMaleEarly
8Py - E - 8EmbalamPuducherryCBJ*2.5 monthsFemaleEarly
9Py - E - 9EmbalamPuducherryCBHF#3 monthsFemaleEarly
10Py - M - 1MadagadipattuPuducherryCBJ*3.5 YearsFemaleMid
11Py - M - 2ThavalakuppamPuducherryCBJ*1.5 monthFemaleMid
12Py - M - 3AriyankuppamPuducherryCBJ*4 monthsFemaleMid
13Py - M - 4ThavalakuppamPuducherryCBJ*3 monthsFemaleMid
14Py - M - 5PillayarkuppamTamil NaduCBJ*1.5 monthFemaleMid
15Py - M - 6VanurTamil NaduCBJ*2 monthsFemaleMid
16Py - L - 1MadagadipattuPuducherryCBJ*2 monthsFemaleLate
17Py - L - 2ThavalakuppamPuducherryCBJ*6 monthsMaleLate
18Py - L - 3ThavalakuppamPuducherryCBJ*3.5 monthsFemaleLate
19Py - L - 4EmbalamPuducherryCBJ*8 monthsFemaleLate
20Py - L - 5KatrankuppamTamil NaduCBJ*4 monthsFemaleLate
21Py - L - 6PillayarkuppamTamil NaduCBJ*3 monthsFemaleLate

CBJ*, Jersey Cross-bred cattle; CBHF#, Holstein-Friesian Cross-bred cattle.

3.2 Clinical findings

Affected cattle exhibited a wide range of clinical symptoms that varied according to the stage of the disease progression. Nodules varied considerably in size and distribution, were round in shape, soft to hard in consistency. In the early stage, clinical findings included mild fever, nasal and lacrimal discharge, brisket and limb edema, reduced milk production, and the presence of mild to moderate cutaneous nodules distributed over the neck, lateral abdomen region, and perineum (Figures 1A–F). These nodules were initially firm, well-circumscribed, and confined to the skin and subcutaneous tissues. During the mid stage of the disease, cattle exhibited higher rectal temperatures, persistent nasal discharge and respiratory distress. Cutaneous nodules were more numerous and distributed over multiple body regions (Figures 2A–D). In the late stage, affected cattle showed respiratory distress and characterized by severe cutaneous nodular lesions. Many nodules underwent necrosis and rupture, resulting in ulcerative wounds, sit-fast lesions, and subsequent scab formation (Figures 3A–D). These lesions were also associated with delayed healing and secondary bacterial infections. Lesions were predominantly distributed over the head, neck, lateral abdomen, limbs, hindquarters, udder and perineal regions. Least frequent observation recorded include brisket and limb edema, decreased milk production, and the presence of severe ulcerative skin lesions associated with secondary complication of skin wounds.

Representative clinical findings in cattle affected with early-stage lumpy skin disease. The image shows **(A)** brisket edema in an adult cow, **(B)** limb edema in a calf, **(C)** cutaneous nodules in the perineal region of a calf, **(D)** lacrimal discharge, **(E)** cutaneous nodules on the neck of an adult cow, and **(F)** cutaneous nodules on the lateral abdominal region of a calf.
Figure 1. Representative clinical findings in cattle affected with early-stage lumpy skin disease. The image shows (A) brisket edema in an adult cow, (B) limb edema in a calf, (C) cutaneous nodules in the perineal region of a calf, (D) lacrimal discharge, (E) cutaneous nodules on the neck of an adult cow, and (F) cutaneous nodules on the lateral abdominal region of a calf.
Representative clinical manifestations observed during the mid stage of lumpy skin disease in cattle. The image illustrates the progression of cutaneous lesions and associated clinical signs in affected animals during the mid stage of infection, including **(A)** lacrimal discharge and cutaneous nodules on the facial region of a calf, **(B)** multiple cutaneous nodules distributed over the facial region, **(C)** generalized cutaneous nodules distributed throughout the body, and **(D)** cutaneous nodules involving the neck and jugular furrow region.
Figure 2. Representative clinical manifestations observed during the mid stage of lumpy skin disease in cattle. The image illustrates the progression of cutaneous lesions and associated clinical signs in affected animals during the mid stage of infection, including (A) lacrimal discharge and cutaneous nodules on the facial region of a calf, (B) multiple cutaneous nodules distributed over the facial region, (C) generalized cutaneous nodules distributed throughout the body, and (D) cutaneous nodules involving the neck and jugular furrow region.
Representative clinical manifestations observed during the late stage of lumpy skin disease (LSD) in cattle. The image illustrates advanced clinical lesions associated with late-stage LSDV infection, including **(A)** respiratory dyspnea accompanied by cutaneous nodules on the limbs of a calf, **(B)** severe scab formation involving the head and neck region of an adult cow, **(C)** extensive scab formation and chronic skin lesions distributed throughout the body of an adult cow, **(D)** characteristic sit-fast lesions in a calf, **(E)** rupture of cutaneous nodules with subsequent wound healing, and **(F)** healing of ruptured nodular lesions characterized by granulation tissue formation.
Figure 3. Representative clinical manifestations observed during the late stage of lumpy skin disease (LSD) in cattle. The image illustrates advanced clinical lesions associated with late-stage LSDV infection, including (A) respiratory dyspnea accompanied by cutaneous nodules on the limbs of a calf, (B) severe scab formation involving the head and neck region of an adult cow, (C) extensive scab formation and chronic skin lesions distributed throughout the body of an adult cow, (D) characteristic sit-fast lesions in a calf, (E) rupture of cutaneous nodules with subsequent wound healing, and (F) healing of ruptured nodular lesions characterized by granulation tissue formation.

3.3 Hematological alterations

The hematological data of LSD affected cattle and healthy controls are presented in Table 3. Significant alterations were observed in erythrocytic and leukocytic indices during the course of infection. Among erythrocytic parameters, TEC showed a significant increase in LSD affected cattle compared with controls (p = 0.049). In contrast, MCV and MCH were significantly reduced in affected animals, particularly in the late stage of disease compared with controls (p = 0.036 and p = 0.013, respectively). No significant differences were observed in PCV, Hb, or MCHC among the study groups (p > 0.05).

Table 3. Compares hematological data of control and LSD affected cattle at different stages of infection.

Parameters (Mean ± SD)ControlEarly - LSDMid - LSDLate - LSDp-value
PCV (%)22.02 ± 8.8022.07 ± 6.1322.92 ± 3.7623.05 ± 1.390.981
Hb (g/dL)7.80 ± 3.137.68 ± 1.328.32 ± 1.348.48 ± 0.490.803
TEC (x106/mm3)5.04 ± 2.035.49 ± 0.706.39 ± 0.966.82 ± 0.690.049
MCV (fL)44.67 ± 7.11a40.11 ± 8.6036.05 ± 3.8533.95 ± 1.77a0.036
MCH (pg)15.70 ± 2.44a13.98 ± 1.7712.98 ± 1.0012.45 ± 0.77a0.013
MCHC (g/dL)35.35 ± 0.8635.56 ± 3.7436.27 ± 1.4936.82 ± 1.630.703
TLC (x103/mm3)4.87 ± 1.09ab9.92 ± 3.85a8.53 ± 3.0813.17 ± 2.21b0.001
Absolute Neutrophil Count (x103/mm3)2.02 ± 0.523.59 ± 2.883.32 ± 1.794.49 ± 1.280.222
Absolute Lymphocyte Count (x103/mm3)2.43 ± 0.85ab5.32 ± 2.04a4.03 ± 1.51c7.22 ± 1.40bc0
Absolute Monocyte Count (x103/mm3)0.32 ± 0.10abd0.76 ± 0.28ac0.94 ± 0.28b1.15 ± 0.21cd0
Absolute Eosinophil Count (x103/mm3)0.10 ± 0.030.25 ± 0.150.24 ± 0.120.28 ± 0.080.043
Absolute Basophil (x103/mm3)0.00 ± 0.01a0.01 ± 0.010.02 ± 0.020.03 ± 0.02a0.007
Platelet Count (x105/mm3)4.26 ± 3.183.30 ± 1.163.90 ± 2.803.03 ± 1.130.738

Different superscripts within the same row indicate significant differences between groups (p* < 0.05) as determined by one-way ANOVA followed by post hoc comparison. P value indicates significance at a 5% level.

Marked alterations were observed in leukocyte profiles. TLC increased significantly with disease progression and was highest in late stage (13.17 ± 2.21 ×10³/mm³), which differed from both control and early stage affected cattle (p = 0.001). Similarly, absolute lymphocyte counts were significantly elevated in infected cattle, with the highest values recorded in late-stage cases (7.22 ± 1.40 ×10³/mm³) compared with controls (p < 0.001). Absolute monocyte counts also increased progressively with disease severity and were significantly higher in late-stage animals than in early-stage, mid-stage and control groups (p < 0.001). Although absolute neutrophil counts tended to be higher in infected cattle than in controls, the differences were not statistically significant (p = 0.222). Significant increases were observed in absolute eosinophil counts (p = 0.043) and absolute basophil counts (p = 0.007) in LSD-affected cattle compared with healthy animals. However, platelet counts did not differ significantly among the groups (p = 0.738). Overall, the hematological profile of LSDV-infected cattle was characterized by leukocytosis, lymphocytosis, monocytosis, eosinophilia, and basophilia, accompanied by reduced MCV and MCH values, indicating systemic inflammatory and immune responses associated with disease progression.

3.4 Diagnosis of LSDV by PCR

PCR targeting partial P32 gene detected LSDV DNA in both nasal swab and skin tissue samples. Out of twenty-one nasal swab samples examined, total 11 samples that is 6 from early stage, 3 from mid stage and 2 from late stage (52.4%) were positive for LSDV. Positivity rate rates were highest in early-stage animals and gradually decreased with disease progression. Among skin tissue samples collected from LSD-affected cattle, 12 samples that is 6 from early stage, 3 each from mid and late stage (57.1%) were positive for LSDV. Positive amplification was observed across different stages of disease, indicating persistence of viral DNA within cutaneous lesions. PCR targeting the partial P32 gene amplified the expected 192 bp product in 11 of 21 nasal swabs and 12 of 21 skin biopsies (Table 4, Figure 4).

Table 4. Presents a comparison of the diagnostic assays used for the detection of LSDV infection in the study.

Sl No.SampleStageNasal swabs - PCRSkin biopsy - PCRIHC
1Py-E-1EarlyPositivePositivePositive
2Py-E-2EarlyPositivePositivePositive
3Py-E-3EarlyPositivePositivePositive
4Py-E-4EarlyPositivePositivePositive
5Py-E-5EarlyPositivePositivePositive
6Py-E-6EarlyPositivePositiveNegative
7Py-E-7EarlyNegativeNegativeNegative
8Py-E-8EarlyNegativeNegativeNegative
9Py-E-9EarlyNegativeNegativePositive
10Py-M-1MidPositivePositivePositive
11Py-M-2MidPositivePositivePositive
12Py-M-3MidPositivePositiveNegative
13Py-M-4MidNegativeNegativeNegative
14Py-M-5MidNegativeNegativeNegative
15Py-M-6MidNegativeNegativeNegative
16Py-L-1LatePositivePositivePositive
17Py-L-2LateNegativePositivePositive
18Py-L-3LateNegativeNegativeNegative
19Py-L-4LateNegativeNegativeNegative
20Py-L-5LateNegativeNegativeNegative
21Py-L-6LatePositivePositiveNegative
Total Positive111210
Positivity rate52.457.183.3
PCR amplification of the partial *P32* gene of lumpy skin disease virus (LSDV) from clinically affected cattle. The agarose gel electrophoresis image shows amplification of the expected 192 bp fragment of the LSDV *P32* gene. Lanes 2–7 represent LSDV-positive clinical samples obtained from affected cattle. PC indicates the positive control, NC represents the negative control, and 100 bp DNA ladder is used as the molecular size marker.
Figure 4. PCR amplification of the partial P32 gene of lumpy skin disease virus (LSDV) from clinically affected cattle. The agarose gel electrophoresis image shows amplification of the expected 192 bp fragment of the LSDV P32 gene. Lanes 2–7 represent LSDV-positive clinical samples obtained from affected cattle. PC indicates the positive control, NC represents the negative control, and 100 bp DNA ladder is used as the molecular size marker.

3.5 Histopathological findings

Histopathology was carried out for LSD-affected animals (n=21). In the epidermis, the epithelium is intact and there were no significant histopathological findings except hyperplasia of the epithelium present in the epidermis. In the dermis, necrosis and severe infiltration of histiocytic cells. There was severe infiltration of histiocytic cells around the perivascular space in the dermis and also in between the muscular bundles present in the deep dermis. These histopathological changes were associated with vasculitis and myositis in the dermis and deep dermis region. Representative images of histochemical staining of LSD-affected skin tissues are shown in Figures 5A–F.

Histopathological alterations in skin tissues of cattle naturally infected with lumpy skin disease virus. The image illustrates the characteristic microscopic lesions observed in affected skin tissues, including **(A)** epidermal hyperplasia of the skin (H&E, ×100), **(B)** marked epidermal hyperplasia at higher magnification (H&E, ×400), **(C)** dermal necrosis characterized by degeneration and loss of tissue architecture (H&E, ×400), **(D)** extensive areas of dermal necrosis with associated inflammatory cell infiltration (H&E, ×400), **(E)** vasculitis in the dermis characterized by inflammatory infiltration surrounding blood vessels (H&E, ×400), and **(F)** myositis in the hypodermis associated with inflammatory cell infiltration and muscle fiber degeneration (H&E, ×400). Red arrows indicate the representative histopathological alterations in each image.
Figure 5. Histopathological alterations in skin tissues of cattle naturally infected with lumpy skin disease virus. The image illustrates the characteristic microscopic lesions observed in affected skin tissues, including (A) epidermal hyperplasia of the skin (H&E, ×100), (B) marked epidermal hyperplasia at higher magnification (H&E, ×400), (C) dermal necrosis characterized by degeneration and loss of tissue architecture (H&E, ×400), (D) extensive areas of dermal necrosis with associated inflammatory cell infiltration (H&E, ×400), (E) vasculitis in the dermis characterized by inflammatory infiltration surrounding blood vessels (H&E, ×400), and (F) myositis in the hypodermis associated with inflammatory cell infiltration and muscle fiber degeneration (H&E, ×400). Red arrows indicate the representative histopathological alterations in each image.

3.6 Immunohistochemical localization of LSDV antigen

Immunohistochemical staining of skin tissues was performed according to the procedure detailed under materials and methods. Among 12 samples (n=6 from early stages, n=3 each from mid and late stages) subjected to immunohistochemistry, 10 samples (n=6 from early stages and n=2 each from the mid and late stages) showed positive immunoperoxidase staining of LSDV. The positive immunoperoxidase staining was observed by the granular golden-brown color in the skin tissues where the LSDV is localized. Representative images of IHC-stained tissues are shown in Figures 6A–F.

Immunohistochemical localization of lumpy skin disease virus antigen in skin tissues of naturally infected cattle. The image demonstrates the distribution of LSDV antigen in cutaneous tissues using the immunoperoxidase technique and Harris hematoxylin counterstain. **(A)** Localization of LSDV antigen within the epidermal layers and hair follicular epithelium (×400). **(B)** Positive immunostaining in the basal layer of the epidermis (×400). **(C)** Localization of viral antigen within the hair follicular epithelium (×400). **(D)** Intense immunoreactivity in the hair follicular epithelium (×400). **(E)** Detection of LSDV antigen in the sweat gland epithelium (×400). **(F)** Localization of viral antigen within the sebaceous glands (×400). Red arrows indicate the specific sites of LSDV antigen localization, visualized as brown immunopositive staining.
Figure 6. Immunohistochemical localization of lumpy skin disease virus antigen in skin tissues of naturally infected cattle. The image demonstrates the distribution of LSDV antigen in cutaneous tissues using the immunoperoxidase technique and Harris hematoxylin counterstain. (A) Localization of LSDV antigen within the epidermal layers and hair follicular epithelium (×400). (B) Positive immunostaining in the basal layer of the epidermis (×400). (C) Localization of viral antigen within the hair follicular epithelium (×400). (D) Intense immunoreactivity in the hair follicular epithelium (×400). (E) Detection of LSDV antigen in the sweat gland epithelium (×400). (F) Localization of viral antigen within the sebaceous glands (×400). Red arrows indicate the specific sites of LSDV antigen localization, visualized as brown immunopositive staining.

In general, LSDV was detected in the cytoplasm of all the epithelial layers of the epidermis but more in the basal layer of the epidermis, the epithelial matrix lining the hair follicle, the epithelial cells of sweat glands and the sebaceous glands. The localisation of LSDV in the epithelial matrix lining the hair follicle was observed in a higher number of cases, followed by the epithelial cell layers of the epidermis and the epithelial cells of sweat glands and sebaceous glands.

3.7 Serological analysis

Indirect ELISA detected antibodies against LSDV in four of twenty-one serum samples, 2 from early stage and one each from mid and late stages. The results correspond to an overall seropositivity rate of 19%. The relatively low seropositivity observed in the present study may reflect variation in the timing of sample collection, differences in individual immune responses and delayed seroconversion in naturally infected animals.

3.8 Expression profiles of cytokine genes from PBMCs and skin tissues

Cytokine expression analysis revealed marked suppression of both Th1- and Th2-associated cytokines in affected cattle compared with healthy controls. Expression of IL-2 was substantially reduced in infected animals, indicating suppression of cell-mediated immune responses. Similarly, IL-4 expression remained lower than control levels, suggesting impairment of humoral immune regulation. IL-10 expression also demonstrated downregulation in affected cattle. The reduced expression of this regulatory cytokine may contribute to immune dysregulation and persistent inflammatory responses. A pronounced reduction in IFN-γ expression was observed in both PBMCs and skin tissues. As IFN-γ plays a critical role in antiviral immunity, its suppression may facilitate viral persistence within host tissues. GM-CSF exhibited marked downregulation compared with healthy controls. Reduced expression of GM-CSF may adversely affect activation and differentiation of innate immune cells, thereby compromising effective antiviral responses.

Overall, the cytokine expression profile demonstrated broad suppression of both systemic and local immune responses in naturally infected cattle. Relative expression patterns of IL-2, IL-4, IL-10, IFN-γ and GM-CSF in PBMCs and skin tissues are presented in Tables 5, 6 respectively.

Table 5. Shows relative expression (fold change ± SD) of cytokine genes in PBMCs of LSDV-infected cattle and healthy controls.

Cytokine geneEarlyMidLateControl
IL-20.00366 ± 0.004840.00725 ± 0.010060.00006 ± 0.000031.00020 ± 0.02798
IL-40.0964 ± 0.13570.0460 ± 0.06480.0003 ± 0.00042.6671 ± 3.4967
IL-100.00348 ± 0.002930.00263 ± 0.003430.00005 ± 0.000041.06595 ± 0.52202
IFN-γ0.03485 ± 0.047720.01506 ± 0.020300.00012 ± 0.000151.69479 ± 1.93511
GM-CSF0.00002 ± 0.000020.00001 ± 0.000010.00000 ± 0.0000012.79644 ± 18.04155

IL-2, Interleukin-2; IL-4, Interleukin-4; IL-10, Interleukin-10; IFN-γ, Interferon-gamma; GM-CSF, Granulocyte-Macrophage Colony-Stimulating Factor; PBMCs, Peripheral Blood Mononuclear Cells.

Table 6. Shows relative expression (fold change ± SD) of cytokine genes in skin tissues of LSDV-infected cattle and healthy controls.

Cytokine geneEarlyMidLateControl
IL-20.00004 ± 0.000040.03950 ± 0.055790.00008 ± 0.000071.09718 ± 0.63845
IL-40.0001 ± 0.00010.4007 ± 0.56660.0003 ± 0.00041.6192 ± 1.8009
IL-100.00001 ± 0.000010.00018 ± 0.000250.00000 ± 0.000001.26938 ± 1.10573
IFN-γ0.00056 ± 0.000780.01686 ± 0.020070.00009 ± 0.0000728.12841 ± 39.75443
GM-CSF0.00000 ± 0.000000.00000 ± 0.000000.00000 ± 0.000001.05228 ± 0.46324

IL-2, Interleukin-2; IL-4, Interleukin-4; IL-10, Interleukin-10; IFN-γ, Interferon-gamma; GM-CSF, Granulocyte-Macrophage Colony-Stimulating Factor.

4 Discussion

The present study provides a comprehensive evaluation of the clinical manifestations, hematological alterations, pathological and diagnostic findings, and cytokine expression profiles associated with LSDV infection in cattle. The majority of affected animals were crossbred cattle, females, and calves, findings that are consistent with previous reports indicating greater disease severity among young and crossbred animals (1, 20, 21).

The clinical findings during sampling reflected the progressive nature of LSDV infection. Early-stage of disease was characterized by fever, lacrimation, edema, and localized cutaneous nodules, whereas mid-stage animals exhibited more extensive skin lesions and respiratory distress. Late-stage cases showed severe respiratory distress, sit-fast lesions, scab formation, rupture of nodules, and wound healing responses. These observations are in agreement with the classical clinical descriptions of LSD reported by Prozesky and Barnard (22) Coetzer and Tuppurainen (23), and Weiss (24) confirming the multisystemic nature of LSDV infection.

Further, molecular diagnosis of the clinical samples targeting the partial P32 gene detected LSDV DNA in both nasal swabs and skin biopsies. Detection rates were higher in skin tissues than nasal swabs, indicating prolonged persistence of viral DNA within cutaneous lesions. These findings support earlier studies demonstrating that skin biopsies remain one of the most reliable samples for LSD diagnosis throughout the course of infection (25). Among the nasal swabs, 11 of 21 animals tested positive, with the highest detection rate occurring during the early stage of disease. The greater PCR positivity in acute phase of infection indicates active viral replication and shedding in respiratory secretions. Similar findings were reported by (26), who demonstrated the presence of LSDV in nasal secretions during early infection. In contrast, the low seropositivity observed by indirect ELISA may reflect delayed antibody development and variability in humoral responses during LSDV infection, as reported previously by (27, 28).

Analysis of blood samples demonstrated significant hematological alterations, including leukocytosis with increased lymphocyte and monocyte counts, particularly in the late stage of disease. These results indicate persistent immune stimulation and inflammatory responses associated with ongoing viral infection. Davies (29)Kitching (30) Tuppurainen and Oura (31) studies showed similar hematological alterations in infected cattle and are considered indicative of host immune activation during disease progression. The observed reductions in MCV and MCH may reflect alterations in erythrocyte dynamics associated with chronic inflammatory processes.

In this study, histopathological analysis of LSD-affected cattle (n=21) revealed significant findings primarily in the dermis and deep dermis, with notable changes in the epidermis. The epidermis of LSD-affected animals showed no significant histopathological findings except for hyperplasia of the epithelium. This finding aligns with previous studies of Prozesky and Barnard (22), who documented epidermal hyperplasia in LSD cases. The intact epithelium with hyperplasia suggests that while the virus causes significant immune responses and tissue changes, it does not necessarily disrupt the integrity of the epidermal layer in the early to moderate stages of the disease. In the dermis, necrosis and severe infiltration of histiocytic cells were observed. The severe infiltration of histiocytic cells indicates a robust immune response to the viral infection. These findings are consistent with the observations by Coetzer and Tuppurainen (23), who noted marked infiltration of inflammatory cells, including histiocytes, in the dermis of LSD-affected cattle. The perivascular space in the dermis also showed severe infiltration of histiocytic cells. This is indicative of vasculitis, which is a characteristic finding in LSD. Vasculitis can lead to increased vascular permeability, resulting in oedema and further recruitment of inflammatory cells to the site of infection. Manjuanthareddy et al., 2024 reported similar findings of perivascular cuffing and vasculitis in LSD cases, highlighting the role of vascular inflammation in the pathogenesis of the disease. Vasculitis, as documented disrupts normal blood flow and contributes to tissue damage and necrosis. Myositis, resulting from both direct viral effects and secondary inflammatory responses, underscores the severity of LSD in advanced stages. Vasculitis and myositis reflect the systemic nature of LSDV infection and its ability to induce widespread inflammatory responses, leading to significant tissue damage.

The immunohistochemical findings in this study enhance the understanding of the tissue tropism in LSD and are consistent with previous reports on the localization of LSDV in skin tissues. According to Al-Salihi and Hassan (32), LSDV exhibits a marked affinity for the basal layer of the epidermis and the hair follicle epithelium, where viral replication and cytopathic effects are prominent. Similarly, a study by (25) demonstrated that LSDV predominantly infects the epidermal and follicular epithelial cells, which are rich in target receptors facilitating viral entry and replication. The predilection of LSDV for the basal layer of the epidermis and the hair follicle epithelial matrix can be attributed to several factors. The basal layer of the epidermis contains proliferative keratinocytes that may provide a favorable environment for viral replication. Additionally, the hair follicle epithelium is known to harbor stem cells with high metabolic activity, which may support efficient viral replication and persistence. The detection of LSDV in the epithelial cells of sweat glands and sebaceous glands, although less frequent, is significant as it suggests that these structures can also serve as sites of viral replication and persistence. This finding is supported by a study conducted by (33), which reported the presence of LSDV antigen in sweat gland epithelial cells, indicating that these glands may contribute to viral shedding and transmission. The extensive involvement of the hair follicle epithelium and basal layer of the epidermis likely contributes to the characteristic nodular lesions and ulcerations observed in LSD. The viral replication in sweat and sebaceous glands may enhance the inflammation and contribute to the secondary bacterial infections commonly associated with LSD.

A notable finding of this study was the marked downregulation of IL-2, IL-4, IL-10, IFN-γ, and GM-CSF in both PBMCs and skin tissues of affected cattle. Their suppression suggests substantial immune modulation during LSDV infection and may represent a viral strategy to evade host immune system and establish persistence. Reduced IL-2 expression suggests impaired adaptive immunity and diminished antiviral responses. Similar suppression of IL-2 during viral infections has been reported by (6), who described cytokine downregulation as a viral immune-evasion strategy. IL-4 promotes Th2 differentiation and antibody-mediated immunity. IL-4 downregulation may compromise antibody production and impair viral neutralization during viral infections which facilitate immune evasion. Downregulation of IL-4 may also contribute to prolonged inflammation due to loss of its anti-inflammatory functions. Similar mechanisms of cytokine dysregulation of IL-10, INF-gamma, and GM-CSF have been reported in LSDV and other viral infections by (34) and Hamilton (35). The collective downregulation of IL-2, IL-4, IL-10, IFN-γ, and GM-CSF in both blood and skin tissues indicates that LSDV induces systemic immune suppression. Similar cytokine modulation has been reported for LSDV by (26) and for other viral infections by (36). (6) further demonstrated that modulation of host immune responses is an important mechanism through which LSDV enhances survival, persistence, and disease severity. Therefore, the observed cytokine suppression likely represents a critical immune-evasion strategy contributing to progression of infection.

A limitation of the present study is that sampling based on stage of disease was obtained from naturally infected cattle rather than from the same animals following longitudinal disease progression. Under field conditions, longitudinal sampling was not feasible because animals were at different stages of infection, and repeated sampling of the same individuals could not be ensured. Consequently, the stage wise comparisons represent cross-sectional observations rather than temporal changes within individual cattle. Nevertheless, the inclusion of naturally infected cattle at distinct clinical stages provides valuable insights into disease alterations with different phases of LSDV infection under field conditions.

The combined use of PCR, histopathology, immunohistochemistry and iELISA can provide a more comprehensive understanding of the infection status and the immune response in affected cattle. These findings provide valuable insights into the pathological modifications underlying the varying clinical outcomes seen in LSDV-affected cattle. These results can be leveraged to develop effective preventive strategies and control measures, ultimately helping to reduce the substantial economic losses caused by the LSD in the cattle population.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Ganesh Sonawane, Central Sheep and Wool Research Institute (ICAR), India

Reviewed by: Manimuthu Prabhu, Tamil Nadu Veterinary and Animal Sciences University, India

Nitin Thakur, Guru Angad Dev Veterinary and Animal Sciences University, India

Statements

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The handling editor GS declared a shared parent affiliation with the authors ST, SB, CR, MB at the time of the review.

Funding

The author(s) declared that financial support was received for this work and/or its publication. This work was supported by research grants from the National Livestock Mission (NLM), DAHD (Grant No. R-300121112022-DADF) and ICAR-NIVEDI (Grant No. ANSCNIVEDISIL202100900123).

Data availability

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/supplementary material.

Ethics approval

The animal studies were approved by Institute Animal Ethics Committee (No. NIVEDI/IAEC/2022/06) of National Institute of Veterinary Epidemiology and Disease Informatics (NIVEDI). The studies were conducted in accordance with the local legislation and institutional requirements. Oral consent was obtained from the owners for the participation of their animals in this study.

Author contributions

GV: Software, Investigation, Formal analysis, Methodology, Writing – original draft. LWA: Supervision, Formal analysis, Writing – review & editing, Visualization, Validation. AAJ: Investigation, Methodology, Formal analysis, Writing – original draft. TS: Supervision, Writing – original draft, Methodology, Software, Investigation. MA: Formal analysis, Writing – original draft, Data curation, Investigation. HKM: Writing – review & editing, Formal analysis, Supervision, Software, Visualization. KR: Validation, Writing – original draft, Methodology, Data curation. SP: Writing – original draft, Methodology, Investigation, Visualization. SU: Supervision, Validation, Writing – review & editing, Formal analysis, Resources. RK: Data curation, Project administration, Resources, Writing – review & editing, Supervision. NMG: Resources, Writing – review & editing, Supervision, Validation, Data curation, Visualization. BS: Formal analysis, Visualization, Validation, Writing – original draft, Software. URC: Software, Writing – original draft, Visualization, Formal analysis, Validation, Methodology, Data curation. GMR: Funding acquisition, Writing – review & editing, Resources, Supervision, Project administration, Conceptualization.

Acknowledgements

The authors acknowledge the Indian Council of Agricultural Research (ICAR) and Director, ICAR-NIVEDI for providing the facility and also express regards and gratitude to the field veterinarians and animal owners for kind cooperation during outbreak investigations.

References

  1. 1 Tuppurainen E, Alexandrov T, Beltran-Alcrudo D. Lumpy Skin Disease–a Manual for Veterinarians. Rome: FAO (2017). p. 1. Available online at: https://openknowledge.fao.org/handle/20.500.14283/i7330en (Accessed July 20, 2026).
  2. 2 Reddy MGB, Kumar N, Tripathi BN. Epidemiology of lumpy skin disease in India - Mini review. Indian J Vet Pathol. (2023) 47: 277–86. doi: doi:10.5958/0973-970X.2023.00051.2
  3. 3 Reddy GBM, Mounica PS, Sudeep N, Vikram R, Garam GB, Lalzampuia H. First evidence of lumpy skin disease in mithun (Bos frontalis) in India. Arch Virol. (2024) 169: 65. doi: doi:10.1007/s00705-024-05996-7
  4. 4 Manjunatha Reddy GB, Pabbineedi SM, Nagaraj S, Bijalwan S, Tadakod S, Bhutia Z. Lumpy skin disease (LSD) in yak (Bos grunniens): An evidence of species spillover from cattle in India. Microorganisms. (2023) 11: 2823. doi: doi:10.3390/microorganisms11122823
  5. 5 Aldeewan AB, Muhsen RK. Clinical and serological study of lumpy skin disease in cattle in Basrah Provence. Kufa J For Veterinary Med Sci. (2019) 10: 99 – 104. doi: doi:10.36326/kjvs/2019/v10i13329
  6. 6 Manjunathareddy GB, Saminathan M, Sanjeevakumar L, Rao S, Dinesh M, Dhama K. Pathological, immunological and molecular epidemiological analysis of lumpy skin disease virus in Indian cattle during a high-mortality epidemic. Vet Q. (2024) 44: 1 – 22. doi: doi:10.1080/01652176.2024.2398211
  7. 7 Naidu GG, Shivappa RR, Rajanna PR, Gondali H, Devaraju MH, Nagesh PKS. Assessment of economic burden of lumpy skin disease in India using stochastic modeling. Sci Rep. (2025) 15: 10160. doi: doi:10.1038/s41598-025-94383-6
  8. 8 Moudgil G, Chadha J, Khullar L, Chhibber S, Harjai K. Lumpy skin disease: A comprehensive review on virus biology, pathogenesis, and sudden global emergence. (2023). doi: doi:10.20944/preprints202302.0074.v3
  9. 9 Bayyappa MRG, Uma CR, Bijalwan S, Tadakod S, Nagaraj S, Naragund M. Molecular epidemiological and spatiotemporal analysis of lumpy skin disease outbreaks in cattle from Karnataka, India. Front Cell Infect Microbiol. (2025) 15: 1596973. doi: doi:10.3389/fcimb.2025.1596973
  10. 10 Jalali SM, Rasooli A, Seifi Abad Shapuri M, Daneshi M. Clinical, hematologic, and biochemical findings in cattle infected with lumpy skin disease during an outbreak in southwest Iran. Arch Razi Inst. (2017) 72: 255–65. doi: doi:10.22092/ari.2017.113301
  11. 11 Das S, Srinivas K, Milton AAP, Khan S, Wahlang L, Kylla H. Epidemiology of lumpy skin disease in Northeast India and a new method for rapid field diagnosis. AMB Express. (2025) 15: 85. doi: doi:10.1186/s13568-025-01891-9
  12. 12 Bayyappa MRG, Nagaraj S, Bijalwan S, Basavarajappa CKH, Shivachandra SB, Gulati BR. Development and validation of a population assay for the seroprevalence of lumpy skin disease. Microorganisms. (2026) 14: 373. doi: doi:10.3390/microorganisms14020373
  13. 13 Parvin R, Chowdhury EH, Islam MT, Begum JA, Nooruzzaman M, Globig A. Clinical epidemiology, pathology, and molecular investigation of lumpy skin disease outbreaks in Bangladesh during 2020–2021 indicate the re-emergence of an old African strain. Viruses. (2022) 14: 2529. doi: doi:10.3390/v14112529
  14. 14 Yadav P, Kumar A, Nath SS, Devasurmutt Y, Shashidhar G, Joshi M. Unravelling the genomic origins of lumpy skin disease virus in recent outbreaks. BMC Genomics. (2024) 25: 196. doi: doi:10.1186/s12864-024-10061-3
  15. 15 Bayyappa MRG, Pyatla MKG, Pabbineedi SM, Gunturu NT, Peela SM, Nagaraj S. Exploring the evolutionary journey of the lumpy skin disease virus through the phylogenetic and phylo-geo network analysis. Front Cell Infect Microbiol. (2025) 15: 1575538. doi: doi:10.3389/fcimb.2025.1575538
  16. 16 Bayyappa MRG, Pabbineedi SM, Nagaraj S, Bijalwan S, Tadakod S, Uma CR. Spatiotemporal epidemiology of lumpy skin disease and evaluation of the heterologous goatpox vaccine: Insights into immunogenicity and impact. Vaccines. (2025) 13: 641. doi: doi:10.3390/vaccines13060641
  17. 17 Ahmad SF, Patra MK, Mahendran K, Paul BR, Khanna S, Singh AK. Hematological and serum biochemical parameters and profiling of cytokine genes in lumpy skin disease in Vrindavani cattle. 3 Biotech. (2023) 13: 66. doi: doi:10.1007/s13205-023-03477-3
  18. 18 Luna LG. Manual of histologic staining methods of the Armed Forces Institute of Pathology. In: Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. New York: McGRAW-HILL BOOK COMPANY (1968). p. xii – 258.
  19. 19 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2- ΔΔCT method. Methods. (2001) 25: 402–8. doi: doi:10.1006/meth.2001.1262
  20. 20 Gari G, Waret-Szkuta A, Grosbois V, Jacquiet P, Roger F. Risk factors associated with observed clinical lumpy skin disease in Ethiopia. Epidemiol Infection. (2010) 138: 1657–66. doi: doi:10.1017/S0950268810000506
  21. 21 Manjunatha Reddy GB, Bijalwan S, Jacob SS, Tadakod S, Maharana SM, Nagaraj S. Investigation of comorbidity and risk factors analysis during lumpy skin disease outbreaks in India. Microorganisms. (2025) 13: 472. doi: doi:10.3390/microorganisms13030472
  22. 22 Prozesky L, Barnard BJ. A study of the pathology of lumpy skin disease in cattle. Onderstepoort J Veterinary Res. (1982) 49: 167–75.
  23. 23 Coetzer JAW, Tuppurainen E. Lumpy skin disease. In: Infectious Diseases of Livestock (Cape Town: Oxford University Press Southern Africa), vol. 2. (2004). p. 1268–76.
  24. 24 Weiss KE. Lumpy skin disease virus. In: Cytomegaloviruses. Rinderpest Virus. Lumpy Skin Disease Virus. Springer Berlin Heidelberg, Berlin, Heidelberg (1968). p. 111–31. doi: doi:10.1007/978-3-662-39771-8_3
  25. 25 Tuppurainen ES, Lubinga JC, Stoltsz WH, Troskie M, Carpenter ST, Coetzer JA. Evidence of vertical transmission of lumpy skin disease virus in Rhipicephalus decoloratus ticks. Ticks Tick-borne Dis. (2013) 4: 329–33. doi: doi:10.1016/j.ttbdis.2013.01.006
  26. 26 Tuppurainen ES, Venter EH, Coetzer JAW. The detection of lumpy skin disease virus in samples of experimentally infected cattle using different diagnostic techniques. Onderstepoort J Veterinary Res. (2005) 72: 153–64. doi: doi:10.4102/ojvr.v72i2.213
  27. 27 Brenner J, Haimovitz M, Oren E, Stram Y, Fridgut O, Bumbarov V. Lumpy skin disease (LSD) in a large dairy herd in Israel, June 2006. Israel J Veterinary Med. (2006) 61: 73–7.
  28. 28 Gari G, Bonnet P, Roger F, Waret-Szkuta A. Epidemiological aspects and financial impact of lumpy skin disease in Ethiopia. Prev Veterinary Med. (2011) 102: 274–83. doi: doi:10.1016/j.prevetmed.2011.07.003
  29. 29 Davies FG. Lumpy skin disease, an African capripox virus disease of cattle. Br Vet J. (1991) 147: 489 – 503. doi: doi:10.1016/0007-1935(91)90019-J
  30. 30 Kitching RP. Vaccines for lumpy skin disease, sheep pox and goat pox. Developments Biologicals. (2003) 114: 161–7. doi: doi:10.1002/9780470753316.ch43
  31. 31 Tuppurainen ESM, Oura CAL. Lumpy skin disease: An emerging threat to Europe, the Middle East and Asia. Transboundary Emerging Dis. (2012) 59: 40–8. doi: doi:10.1111/j.1865-1682.2011.01242.x
  32. 32 Al-Salihi KA, Hassan IQ. Lumpy skin disease in Iraq: Study of the disease emergence. Transboundary Emerging Dis. (2015) 62: 457–62. doi: doi:10.1111/tbed.12386
  33. 33 Haegeman A, De Leeuw I, Mostin L, Van Campe W, Aerts L, Vastag M. An immunoperoxidase monolayer assay (IPMA) for the detection of lumpy skin disease antibodies. J Virological Methods. (2020) 277: 113800. doi: doi:10.1016/j.jviromet.2019.113800
  34. 34 Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. (2001) 19: 683 – 765. doi: doi:10.1146/annurev.immunol.19.1.683
  35. 35 Hamilton JA. GM-CSF in inflammation and autoimmunity. Trends Immunol. (2002) 23: 403–8. doi: doi:10.1016/S1471-4906(02)02260-3
  36. 36 Chihota CM, Rennie LF, Kitching RP, Mellor PS. Attempted mechanical transmission of lumpy skin disease virus by biting insects. Med Vet Entomol. (2003) 17: 294 – 300. doi: doi:10.1046/j.1365-2915.2003.00445.x

Citation

Vigneshwar, G., et al. (2026). Immuno-pathological studies of lumpy skin disease outbreaks in cattle. Frontiers in Virology, Volume 6. https://doi.org/
Received
Accepted
Published
Volume
6 - 2026

Copyright

Copyright © 2026 Vigneshwar, Avinash, Javed, Sunil, Abhinaya, Mukhopadhyay, Rajalakshmi, Poobitha, Uma, Kumar, Gopalakrishnan, Sharddha, Chandana and Manjunatha Reddy.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Gundallahalli Bayyappa Manjunatha Reddy

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0